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Abstract 
Recent advances in proteomics and mass-spectrometry have widely expanded the 
detectable peptide repertoire presented by major histocompatibility complex (MHC) 
molecules on the cell surface, collectively known as the immunopeptidome. Finely 
characterizing the immunopeptidome brings about important basic insights into the 
mechanisms of antigen presentation, but can also reveal promising targets for vaccine 
development and cancer immunotherapy. In this report, we describe a number of practical 
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and efficient approaches to analyze immunopeptidomics data, discussing the identification of 
meaningful sequence motifs in various scenarios and considering current limitations. We 
address the issue of filtering false hits and contaminants, and the problem of motif 
deconvolution in cell lines expressing multiple MHC alleles, both for the MHC class I and 
class II systems. Finally, we demonstrate how machine learning can be readily employed by 
non-expert users to generate accurate prediction models directly from mass-spectrometry 
eluted ligand data sets. 
 
Introduction 
The comprehensive set of peptides presented on the cell surface by MHC molecules, 
collectively referred to as the immunopeptidome, represents a unique fingerprint of the 
health of a cell. T lymphocytes routinely scan this pool of MHC-associated peptides, and can 
help eliminating infected or cancerous cells that present abnormal peptides on their surface. 
MHC class I molecules mainly bind peptides derived from intracellular pathogens (such as 
viruses and some bacteria) and present them to cytotoxic T lymphocytes; MHC class II 
epitopes are mainly derived from extracellular proteins and are presented to T-helper 
lymphocytes. 
Recent technological advances in the field of mass spectrometry (MS) have brought about a 
revolution in the study of immunopeptidomes (reviewed in ref. [1]), with several thousands of 
peptides that can be detected in a single experiment. Large data sets of naturally presented 
peptides have been beneficial to define more accurately the rules of peptide-MHC binding 
[2–4] but have also a tremendous potential in defining pathogen-derived T cell epitopes [5,6] 
and neo-epitopes unique to cancerous cells [7–10]. Part of the appeal of MS-based 
approaches is that they do not require prior knowledge of MHC motifs, and there is no 
human intervention in defining a library of candidate sequences to be tested. Therefore, MS 
provides a large but relatively unbiased sampling of the population of processed and 
presented peptides available for T cell recognition [3]. 
In most MS-based pipelines, spectra from eluted peptides are matched against a reference 
database of natural proteins using algorithms like MaxQuant [11] or PEAKS [12,13], and 
filtered against a decoy database to limit the false discovery rate (FDR). Strict FDR filters 
(typically in the order of 1%) should ensure that most spectra are correctly assigned to bona 
fide ligands, but often leads to discarding a large portion of the spectra. Several approaches 
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have been proposed to increase the yield of spectral assignment. For example, Mascot 
Percolator performs machine learning on high-confidence matches to re-score database 
search results for lower-confidence peptides [14]. Instead of matching spectra to an entire 
protein database, SpectMHC constructs reduced, targeted databases of potential MHC 
ligands, effectively reducing the amount of spurious decoy hits [15]. Recent work has also 
suggested that a portion of the unassigned spectra may also be explained by proteasome-
generated spliced peptides, which would require the inclusion of spliced variants in the target 
database [16,17]. 
After spectral assignment to amino acid sequences, peptides must often be aligned and/or 
clustered to extract meaningful sequence motifs of antigen presentation. The analysis 
protocols here will generally differ depending on the type of receptor (MHC I vs. MHC class 
II) and type of sample used (cellular versus soluble MHC molecules and mono- vs. poly-
allelic cell lines). MHC I ligands have a limited range of lengths, typically 8 to 11 amino acids 
long, and are characterized by very conserved amino acid preferences at the positions 
interacting with the MHC binding groove (anchor positions). On the other hand, MHC II 
ligands are normally longer, with only a portion, the binding core, directly interacting with the 
MHC groove [18]; in this case a more sophisticated alignment process is needed to extract 
conserved binding preferences. In transgenic cells expressing a single MHC molecule 
(mono-allelic), only one specificity is expected to be present in the data and motif 
identification is relatively straightforward. Conversely, unmodified cells will naturally present 
peptides bound to multiple MHC alleles (up to six for HLA class I), with generally different 
binding preferences; in this case, the multiple specificities contained in the data must be 
deconvoluted, either by assigning MHC restriction with predictive methods, or by 
unsupervised clustering. 
A popular tool for the unsupervised identification of sequence motifs in immunopeptidomes 
is GibbsCluster [19,20], a web-based and downloadable method that has been included into 
numerous pipelines for the deconvolution of ligand motifs in the MHC class I [21–23,10] and 
MHC class II [24–26] systems. The GibbsCluster algorithm takes as input a list of peptide 
sequences (potentially of variable length), and uses a heuristic search to group them into 
information-rich groups. Besides the sequence motif defining each group, additional 
properties such as the ligand length distribution of each cluster can be analyzed. A similar 
method, MixMHCp [2,27], has shown performance comparable to GibbsCluster, with the 
limitation that it can only handle peptides of uniform length. A useful feature of GibbsCluster 
is the “trash cluster”, a check on internal motif consistency that can filter out outliers that 
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cannot be assigned to any clusters. In the context of MS eluted ligand data, spurious data 
points can originate both from LC-MS/MS contaminants and from erroneous spectral 
matches. As a noise filter, GibbsCluster can be beneficial also for mono-allelic data sets 
where no motif deconvolution is required.  
While sequence motifs are generated by GibbsCluster in an unsupervised manner, the 
method cannot directly assign the MHC restriction of each ligand; this must be done by 
comparing the unsupervised motifs with published binding motifs of the MHC molecules in 
the sample [28]. While this comparative approach is in most cases feasible for human MHC, 
whose most prevalent alleles have been well characterized and documented, it will fall short 
for samples containing uncharacterized specificities. Aiming to overcome this limitation, 
Bassani-Sternberg et al. [27] suggested a strategy for automatic, unbiased annotation of 
MHC restriction by comparing motifs detected in multiple data sets with known haplotypes. 
Exploiting the co-occurrence of MHC alleles across different data sets, they were able to 
assign motifs to individual alleles without relying on a priori assumptions on their binding 
specificity, also for alleles without previously documented ligands. 
Over the past decades, many efforts have been dedicated to the development of 
computational methods for the prediction of peptide binding to MHC class I molecules. Most 
of these T-cell epitope prediction methods have been traditionally trained solely on in-vitro 
data of peptide-MHC binding affinity. Although peptide-MHC affinity is arguably the most 
selective step in antigen presentation, other factors influence the likelihood of a peptide 
being presented on the cell surface for T-cell recognition [29,30]. In-vitro binding affinity data 
does not address the fact that antigen presentation is a complex, integrative physiological 
process that combines antigen processing, transport and binding affinity/stability of the 
peptide-MHC complex. Finally, in-vitro data fails to reflect any peptide length preference of 
different MHC-I alleles. Because naturally eluted ligands incorporate information about these 
additional properties of antigen presentation, large MS-derived sets of peptides can 
potentially enable the generation of more accurate prediction models. Recent studies have 
suggested that models trained on MHC class I ligand data outperform binding affinity-based 
predictors when it comes to identification of eluted ligands and T cell epitopes, both in an 
allele-specific setting [2,3] as well as with pan-allelic coverage [4]. Generic tools for machine 
learning from peptide sequences such as NNAlign [31,32] can be applied to individual MS 
data sets to generate custom-made prediction models, which can in turn be employed for 
further downstream analyses of the immunopeptidome. 
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The rapidly expanding collection of naturally eluted ligands revealed by MS and the analysis 
toolkits developed in its wake hold great promise in understanding the structure of the 
immunopeptidome and the rules of antigen presentation. However, because of the 
complexities inherent to MS eluted ligand data, it is not a trivial task to analyze and interpret 
the information these data sets contain. In this report, we seek to address some common 
issues and describe strategies to analyze MS ligand data and derive sequence motifs in the 
various scenarios outlined above (MHCI vs. MHCII; mono-allelic vs. poly-allelic cell lines), 
with guidelines and examples on publicly available datasets. 
 
MHC class I; mono-allelic cells 
In a recent publication, Abelin et al. [3] described the development of transgenic cells that 
express a single human MHC class I allele (HLA), and used them to generate a large set of 
MHC ligands covering 16 HLA class I alleles. There are obvious advantages in using mono-
allelic cells to characterize MHC ligands: firstly, no deconvolution/clustering is required to 
define motifs at the single-allele resolution; secondly, the assignment of individual peptides 
to their allele does not have to depend on binding predictions or prior knowledge of the 
motifs. Apart from technical difficulties in the cell generation, a possible drawback is that the 
relative level of expression of different MHC alleles in a given cell, and the amount of ligands 
they present, is lost in a mono-allelic setting. The amount of ligands presented by different 
alleles may also depend on competition between MHC molecules, where the newly available 
digested peptides from an unfolding antigen fragment would presumably be captured by 
MHCs with the highest affinity [33].  
Although most software for MS spectra mapping uses a strict false discovery rate (FDR) 
threshold, incorrect ligands may still be present among the matches that pass the FDR 
check. These may consist of common contaminants such as keratin or histone proteins, as 
well as residual peptides from previous runs of the LC-MS/MS instruments used for sample 
preparation [34,35]. GibbsCluster is a useful tool to detect and remove such contaminants 
and false hits. For each allele in the Abelin data set [3], we applied GibbsCluster-2.0 with 
default preset options for “MHC class I ligands of length 8-13”, specifying a single cluster. 
Between 0.4% and 16% of the peptides (mean 4%) of length 8 to 13 were inconsistent with 
the motif identified by GibbsCluster-2.0 and were removed by the program as noise. While 
distinct motifs can be discerned before trash cluster filtering (see three representative alleles 
in Figure 1A), the post-filtering motifs have higher information content and more well-defined 
www.proteomics-journal.com Page 6 Proteomics 
 
 
This article is protected by copyright. All rights reserved. 
 
anchor residues (Figure 1B). Peptides in the “trash cluster” may sometimes hint at the origin 
of the contamination: for example, the observation of terminal Arginine/Lysine preferences at 
the C-terminus in several of the 16 alleles points towards tryptic peptides polluting the 
mixtures (Supplementary Figure S1). The ligands in the Abelin data set have in general very 
good correspondence to known MHC binding preferences, with an average NetMHCpan-3.0 
percentile rank [36] well below 1% for most alleles (Figure 1C, red boxplots). In contrast, 
peptides in the trash cluster match very poorly the preferences of their MHC and are 
assigned high NetMHCpan rank scores  (Figure 1C, blue boxplots). 
 
MHC class I; poly-allelic cells 
Unmodified antigen-presenting cells will generally express up to six different MHC class I 
alleles (two each for HLA-A, HLA-B and HLA-C). The immunopeptidome of these cells 
therefore consists of multiple specificities mixed together, where the global haplotype is 
known but the restriction of each individual ligand is unknown. For example, Bassani-
Sternberg et al. [21] described the LC-MS/MS analysis of peptides eluted from seven 
different cancer cell lines and primary cells, which had been HLA-typed at high resolution, 
and demonstrated how the GibbsCluster approach could be used to deconvolute the 
individual peptide restrictions. Here we illustrate the application of GibbsCluster to one of the 
cell lines from the Bassani-Sternberg study, HCC1143, which expresses the five alleles 
HLA-A*31:01, HLA-B*35:08, HLA-B*37:01, HLA-C*04:01, HLA-C*06:02. 
GibbsCluster finds an optimal solution of four clusters, with a close correspondence to all but 
one of the HC1143 alleles (Figure 2), failing to separate HLA-C*04:01 ligands. HLA-C 
molecules have low expression levels and rather degenerate binding preferences [27,37], 
making the deconvolution of their motifs more challenging. The motifs determined by 
unsupervised clustering show a remarkable correspondence with the binding preferences 
predicted by NetMHCpan-3.0 [36]. There are, in some instances, subtle differences between 
the NetMHCpan and GibbsCluster motifs, as in the case of additional secondary anchors 
(e.g. a positively charged P5 for HLA-B*37:01). This suggests that motifs directly derived 
from eluted ligands may carry an additional level of information on peptide presentation (for 
instance, secondary anchors conferring improved peptide-MHC complex stability) compared 
to the NetMHCpan motifs, which were constructed from in vitro binding affinity data. The 
sizes of the clusters give an indication of the relative level of expression of the different 
alleles, with the largest group corresponding to the homozygous HLA-A*31:01 (1253 
www.proteomics-journal.com Page 7 Proteomics 
 
 
This article is protected by copyright. All rights reserved. 
 
peptides), followed by the two HLA-B alleles (610 and 460 peptides respectively) and by the 
lowly-expressed HLA-C*06:02 (409 peptides). Finally, 45 peptides were collected by the 
trash cluster. Interestingly, for six out of seven cell lines in the Bassani-Sternberg data set, 
we noted a C-terminal enrichment for Arginine/Lysine in peptide discarded in the trash 
cluster (Supplementary Figure S2). A similar observation was made for the Abelin data set 
discussed previously, and hints that residual peptides derived from trypsin digestion may 
often be present in the LC column. 
As an alternative approach to unsupervised clustering, one can assign each peptide to a 
MHC allele using peptide-MHC binding prediction methods; then deriving sequence motifs 
from the resulting groups of peptides. We applied NetMHCpan [36] to the peptides eluted 
from the HCC1143 cell line, assigning peptides to the MHC molecule in the haplotype with 
the lowest predicted NetMHCpan percentile rank. If a peptide could not be assigned to any 
MHC molecule with rank<=2%, then it was discarded in a trash cluster. While this setup 
mimics the GibbsCluster strategy, it has the very important difference that NetMHCpan 
utilizes known motif preferences of the MHC molecules to make the assignments, whereas 
GibbsCluster is unsupervised and requires no prior knowledge of the motifs. In the case of 
the HCC1143 cell line, the MHC molecules are all well characterized and the solutions found 
by the two approaches are remarkably similar (Supplementary Figure S3). Assignment by 
NetMHCpan has the potential advantage that at least a fraction of peptides could be 
assigned to HLA-C*04:01, a specificity that was not detected by unsupervised clustering. 
However, in cases where the haplotype is not fully characterized, or when the known MHC 
alleles have poorly studied motifs, the assignment by NetMHCpan would fail. This is 
exemplified by a recent study of bovine MHC ligands [38], for which the motifs derived by 
GibbsCluster differed dramatically from the assignments made by NetMHCpan due to 
paucity of training data available to NetMHCpan for these alleles. Note also, that the number 
of ligands discarded to the trash cluster using this approach was more than 10 times higher 
compared to those discarded by GibbsCluster (463 versus 45). 
 
MHC class II, mono-allelic cells 
Analyzing MHC class II binding data is for many reasons more complex compared to MHC 
class I. First and foremost, the HLA class II binding groove is open at both ends, 
accommodating peptides of a wide range of length by letting them protrude at either 
terminus of the nonamer binding core. Sophisticated alignment methods are therefore 
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required to identify the conserved binding preferences of MHC class II molecules [39–41]. 
Secondly, the binding motifs for MHC class II are in general more degenerate compared to 
the highly conserved MHC class I motifs [42,43]. These observations make the analysis and 
interpretation of MHC class II binding data, including MS ligands, highly challenging.  
In a recent paper by Ooi et al. [44], MS eluted ligand data were used to investigate how 
patients expressing different HLA class II alleles have different susceptibility to autoimmune 
diseases. To characterize the specificity for each allele, they generated transgenic mice 
bearing the human HLA-DR1 MHC class II allele. On these data, we illustrate how the 
GibbsCluster method can be used to identify the binding motif of MHC class II molecules 
from mono-allelic MS ligand data and at the same time remove potential outliers. The 5740 
non-redundant raw eluted peptide sequences were uploaded to the GibbsCluster web 
server, setting the recommended preset parameters for MHC class II peptides, except for 
the number of iterations per sequence per temperature step (set to 100) and the number of 
temperature steps (set to 50); these parameters entail a slower, but more accurate, motif 
search. The method recovered the binding motif for allele HLA-DRB1*01:01, with strong 
amino acid preferences at anchor residues at P1, P4, P6 and P9 (Figure 3A). These 
preferences were observed both without (Figure 3A, left panel) or with a trash cluster 
activated (Figure 3A, right panel). By activating the trash cluster option with a threshold of 2, 
179 peptides (3% of data) were removed, and the logo showed a 20% increase in 
information content (Figure 3A, right panel).  
 
MHC class II, poly-allelic cells 
Another data set obtained from the Ooi et al. study [44] consists of peptides eluted from 
HW09013 cells that express the HLA-DR15/DR51 class II alleles. On this poly-allelic data 
set of MS eluted ligands, we set out to demonstrate how the GibbsCluster can be used to 
separate multiple specificities in MHC class II ligand data. The set of 2782 unique eluted 
peptides was submitted to GibbsCluster, using the recommended preset parameters for 
MHC class II and allowing the program to search up to three clusters. The unfiltered, single-
cluster solution shows a motif with the correct P1, P4, P6 and P9 anchor positions, but with 
low information content and preferences that are a mixture of the two alleles in the sample 
(Figure 3B, left panel). Activating the trash cluster with a threshold of 2, the maximum 
information content is observed for the solution with two clusters (Figure 3B, right panel). 
The amino acid preferences identified by GibbsCluster resemble previously published motifs 
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derived from binding affinity data for HLA-DRB1*15:01 and HLA-DRB5*01:01 [31,45], and 
closely overlap with the global peptidome of DR15/51 characterized in a recent study [46]. 
Specifically, cluster 1 was composed of 1610 peptides (57.9%) and its motif resembles the 
HLA-DR15 binding preferences; cluster 2 comprised 1050 peptides (37.7%) and 
corresponds to the HLA-DR51 alleles; 122 peptides (4.4%) did not match to either group and 
were collected by the trash cluster. 
In order to validate the solutions generated by GibbsCluster, we examined the composition 
of the clusters in terms of binding potential predicted by NetMHCIIpan-3.1 [47]. Both for the 
mono-allelic DR1 and poly-allelic DR15/51 serotypes discussed above, we obtained 
predicted percentile rank scores for all peptides in the cluster solutions and in their relative 
trash cluster (Figure 4). The predicted median rank score for HLA-DRB1*01:01 in the DR1 
cluster was 4% (first quartile (Q1)=0.9, third quartile (Q3)=12), whereas the trash cluster had 
a median rank score of 41% (Q1=20.5, Q3=75). In the poly-allelic data, cluster 1 was 
associated with HLA-DRB1*15:01, and showed a median rank score of 13% (Q1=5, Q3=30); 
cluster 2 was associated to HLA-DRB5*01:01 and obtained a median rank score of 4% 
(Q1=1.1, Q3=11); peptides in the trash cluster were evaluated against both alleles, assigning 
the best rank of the two, which resulted in an average rank score of 41% (Q1=23, Q3=75) 
(Figure 4). Overall, the NetMHCIIpan percentile score distributions suggest that the trash 
cluster could successfully collect peptides with very poor correspondence to the known 
preferences of the MHC class II molecules, and that probably derived either from incorrect 
spectral matches or from contaminants. The relatively high predicted rank values for the 
peptides mapped to the HLA-DRB1*15:01 cluster further suggest that the binding motif for 
this molecule predicted by NetMHCIIpan-3.1, which was trained on binding affinity data, 
shared a rather weak overlap with the binding motif contained within the MS ligand data. 
This observation underlines the high potential of MS ligand data to complement our 
knowledge on peptide characteristics required for MHC antigen presentation, as previously 
remarked for MHC class I [2–4,21,23].  
 
Generating prediction models from MS ligand data 
The approaches described so far in this report are mainly concerned with extracting and 
visualizing meaningful patterns within complex, often noisy, mixtures of peptides sequences. 
A further step is the generalization of the motifs identified in the data at hand, by constructing 
prediction models. Machine learning algorithms such as NNAlign [32], when provided with 
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training examples suitably labeled (e.g. ligands vs. non-ligands),  can be instructed to 
automatically learn the features that distinguish positive from negative examples. Such 
models can then be applied on external data sets to discover more occurrences of the 
patterns learned on the training data. In the context of peptide-MHC interactions, a good 
prediction model should have the ability to capture the binding preferences contained in the 
training data, both in terms of sequence motifs and peptide length distribution. In the next 
two sections, we illustrate some simple examples of prediction models directly constructed 
from MHC class I and class II eluted ligands. 
 
MHC Class I prediction model 
As an example application, we continue with the Abelin ligand elution dataset previously 
analyzed and filtered using GibbsCluster-2.0 (Figure 1). For each of the representative 
alleles HLA-A*68:02, HLA-B*35:01 and HLA-B*57:01, we prepared a training set consisting 
of post-filtering ligands (positive instances) and random natural peptides (negative 
instances). Positive instances were labeled with a target value of 1, negatives with a target 
value of 0. In line with earlier work [4], the amount of random negatives was imposed to be 
the same for each length 8 to 13, and corresponded for each length to five times the amount 
of positives for the most abundant peptide length.  This uniform length distribution of the 
random negatives was adopted as a background against with machine learning can be 
employed to learn the amino acid and length preference of the natural binders. 
On each of the three data sets, we trained a prediction model with the NNAlign-2.0 
webserver, using the recommended preset options for MHC class I ligands of variable 
length. In a cross-validation experiment, the three models returned an area under the ROC 
curve (AUC) of 0.961, 0.984 and 0.979, respectively. In order to derive the amino acid and 
peptide length preferences learned by the model, we used it to evaluate a large set of 
900,000 random natural peptides with a flat length distribution, and extracted the top 0.1% 
scoring peptides. The composition of these high-scoring peptides should reflect the main 
preferences identified by the method to distinguish positive from negative instances. Indeed, 
the binding motif drawn from the top 0.1% peptides closely reflects the amino acid 
preferences of the training data (Figure 5A-B). Moreover, all three methods could capture 
the preference for 9mer peptides over other peptide lengths; 10mers were moderately 
allowed, 8mers and 11mers were observed more infrequently (Figure 5C). 
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MHC Class II prediction model 
To illustrate how the NNAlign framework can be used to construct MHC class II prediction 
models, we go back to the DR1 and DR15/51 data sets from Ooi et al. [44] previously filtered 
and clustered with GibbsCluster (Figure 3). To enrich the positive instances with artificial 
negative examples, a set of natural random negatives of length 11 to 19 amino acids was 
added to each eluted ligands data set. Positive instances were labeled with a target value of 
1, negatives with a target value of 0. Similarly to the training set preparation described above 
for MHC class I, the amount of random negatives for each length corresponded to five times 
the amount of positives for the most abundant peptide length. For each of the three 
specificities deconvoluted by GibbsCluster in the DR1 and DR15/51 cells, we applied 
NNAlign-2.0 to generate a prediction model, using the preset parameters for MHC class II 
recommended by the NNAlign server. For the mono-allelic DR1 serotype, all ligands except 
those removed by the trash cluster were used to train a model. For the DR15/51 cells, for 
which the clustering analysis revealed two separate specificities, we generated a separate 
model from the ligands contained in each of the two clusters. 
The three models revealed high internal consistency, with cross-validated performance of 
AUC=0.952, 0.974 and 0.952, respectively. NNAlign automatically generates a matrix (and 
logo) representation of the motif learned by the method, constructed from the top 1% scoring 
predictions from a large set of random natural peptides. We may compare the motifs learned 
by NNAlign to: i) the binding preferences in the MS training data, identified by GibbsCluster; 
ii) the GibbsCluster motifs identified in tetramer-validated epitopes extracted from the IEDB 
for the three DR molecules; iii) the binding preferences predicted by NetMHCIIpan-3.1 for 
these DR molecules. In general, the motifs learned by the NNAlign models share a 
remarkable overall correspondence to the preferences found by GibbsCluster for the MS 
ligand data, with similar amino acid enrichments at the anchor positions P1, P4 and P6, as 
well as the strong P9 for the DR51-associated ligands (Figure 6, first and second columns). 
Likewise, the binding motifs constructed from the rather small amount of tetramer-validated 
epitopes obtained from the Immune Epitope Database (IEDB) [48] for the three DR 
molecules (231 for HLA-DRB1*01:01, 129 for HLA-DRB1*15:01, 73 for HLA-DRB5*01:01) 
correspond well with the motifs of the NNAlign models, and the MS ligand data (Figure 6, 
third column). In contrast, the logos derived from in-vitro binding affinity data (NetMHCIIpan) 
in all cases show substantial differences to both the MS- and epitope-derived motifs (Figure 
6, fourth column). These discrepancies are most pronounced for HLA-DRB1*15:01, where 
the NetMHCIIpan motif has weakly defined preferences at the anchor residues, and an 
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enrichment of arginine (R) throughout the binding motif; a preference that is completely 
absent from the MS and epitope-derived motif. Another, more subtle difference is the 
enrichment of glutamic acid (E) at P4 in the MS and epitope motifs for HLA-DRB1*01:01; this 
preference is absent in the NetMHCIIpan motif. Finally, NetMHCIIpan displays a preference 
for R/K at position P8 for HLA-DRB5*01:01; this anchor is completely absent in the motif 
derived from MS and tetramer-validated epitope data. Taken together, these results show 
that ligand elution is a stronger correlate of epitope presentation than peptide-MHC binding 
affinity, suggesting that epitope prediction models may greatly benefit from incorporating MS 
eluted ligand data. 
 
Final remarks 
The binding specificities of MHC molecules have been traditionally characterized using in-
vitro assays of binding affinity. The peptide-MHC binding data amassed through decades of 
painstakingly low-throughput experiments have had a tremendous contribution to the 
characterization of the binding preference for the most prevalent MHC molecules, and more 
generally to the understanding of the peptide repertoire available for T cell recognition. 
However, because of the extreme polymorphism of the MHC-encoding genes, with up to 
several thousand allelic variants per locus, the full characterization of their specificities 
remains infeasible. Tandem mass-spectrometry has emerged in the past decade has a 
powerful, high-throughput alternative for the identification of peptides eluted on the surface 
of antigen-presenting cells. 
The appeal of MS-based techniques does not only reside in the sheer amount of ligand data 
that can be detected in a single experiment. Because MS ligands are derived from a 
biological system that incorporates all properties of antigen presentation including binding 
affinity, binding stability, proper peptide processing and translocation, and impact of MHC 
binding chaperones, these techniques should capture additional signals besides the binding 
affinity measurable by in-vitro assays. Accurate tools for the identification of sequence motifs 
in eluted ligand datasets are essential to interpret the patterns underlying the 
immunopeptidome and to benefit from this data deluge. 
In this report, we described some straightforward, efficient approaches to extract motifs from 
immunopeptidomes in a number of scenarios commonly encountered in the field. We 
outlined analyses for MHC class I and class II, both in cell lines expressing a single MHC 
allele and in unmodified cells with multiple MHC allelic variants. GibbsCluster [20] is our tool 
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of choice because it can effectively remove residual contaminants after FDR filtering, 
deconvolute multiple motifs in a mixture of peptides of variable length and because it works 
both for MHC class I and class II ligands. In general, MHC class I molecules have strong, 
well-defined motifs, and even in samples containing several specificities it is often feasible to 
separate them into individual clusters. An unresolved problem remains the unambiguous 
association of each cluster to individual MHC molecules, especially for alleles with unknown 
binding motifs. So far only Bassani et al. [27] have attempted to tackle this question, 
exploiting the co-occurrence of MHC class I alleles across different data sets of known 
haplotype to assign motifs to individual alleles. More work along these lines is needed to 
automatically annotate the MHC restriction of peptides in poly-allelic datasets. The current 
implementation of GibbsCluster assumes that each peptide is restricted to one and only one 
MHC molecule. When cells express different alleles with similar binding motifs, or in the case 
of MHC class II ligands binding to multiple alleles in different alignment frames, it is likely 
that an individual peptide can act as ligand for multiple MHCs in a mixture. Future 
improvements to the algorithm should aim to address this limitation and account for potential 
multiple restrictions of individual ligands. 
Ultimately, prediction methods can only be as good as the data used to train them. While 
MHC ligands sequences obtained by mass-spectrometry show remarkable reproducibility 
and produce binding motifs consistent with those derived with more low-throughput assays, 
there remain several potential sources of error and bias in MS-based pipelines for ligand 
sequencing. For example, there is a documented underrepresentation of cysteine in MHC 
ligand data sets, as this amino acid interferes with MS precursor fragmentation [3,27]. 
Different software tools for spectrum-peptide mapping use different functions to score 
candidate sequences, and they will generally identify non-identical sets of ligands. Post-
translational modifications (PTMs) have also been shown to have a role in shaping the MHC 
ligand repertoire [49].However, accounting for such modified residues further complicates 
accurate spectrum-peptide matching and PTMs are often not comprehensively considered in 
MS pipelines. Finally, common contaminants such as keratin and histone proteins are often 
co-eluted with MHC ligands and add a level of noise to the sequenced immunopeptidome 
[34,35]. Reducing biases and sources of error in the data-generation pipelines will also 
inevitably affect in a positive way the data interpretation and the prediction tools constructed 
on these data.  
A number of recent reports have described the first prediction methods trained directly on 
MHC class I ligand elution data from MS [3,4,28,50]. Their results indicate that methods 
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trained on naturally presented peptides largely outperform prediction methods trained solely 
on in-vitro binding affinity data when it comes to identification of MHC ligands and epitopes. 
No reports have yet been published on models directly trained on MHC class II eluted 
ligands. Because the performance of MHC class II prediction methods still lags far behind 
their class I counterparts for epitope prediction, antigen processing factors are likely to play a 
major role in the generation of MHC class II ligands. Incorporating naturally processed ligand 
from MS experiments in the training pipelines of MHC class II prediction methods is an 
exciting and yet unexplored opportunity to close that gap. A simple but powerful approach to 
generate prediction models from ligand data is the NNAlign method [32]. We illustrate the 
construction of models from MS eluted ligands both for MHC class I and MHC class II, and 
show that they capture the preferences of the training data both in terms of binding motif and 
ligand length distribution. Taken together, these computational tools allow researchers to 
interpret motifs contained in immunopeptidomes and generate prediction models to scan 
protein databases for epitope candidates. 
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Figure legends 
Figure 1. Visualizing motifs and removing contaminants with GibbsCluster. A) Sequence motifs 
of three representative alleles before trash cluster filtering and B) after filtering. The post-filtering 
motifs have higher information content and lack the putative K/R contamination at P9. C) Distribution 
of NetMHCpan-3.0 percentile rank scores for peptides in the main cluster (red) and in the trash cluster 
(blue).  
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Figure 2. Clustering results for the HCC1143 cell line. The single cluster solution (left) is a mixture 
of multiple specificities, dominated by the most abundant alleles. The solution with highest information 
content corresponds to four clusters, with motifs highlighted in the red box (center). The motifs 
identified by unsupervised clustering show a remarkable correspondence with those predicted by 
NetMHCpan-3.0 (right). The GibbsCluster method was run using the default preset parameters for 
“MHC class I ligands of length 8-13”, except for the num er of iterations which was set to 1   (slower 
but more accurate), and number of groups, which was allowed to vary between 1 and 6. NetMHCpan 
logos were obtained from the NetMHCpan-3.0 website (http://www.cbs.dtu.dk/services/NetMHCpan-
3.0/logos.php), and were constructed from the top 1% scoring peptides from a large set of natural 
random peptides. 
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Figure 3. Sequence motifs identified by GibbsCluster-2.0 on MHC class II ligand data. The 
method identifies distinct amino acid preferences at the anchor positions P1, P4, P6 and P9 both 
without (left panels) and with (right panels) the trash cluster activated. (A) Visualizing the motif and 
removing outliers from the mono-allelic human-DR1 mouse-transfected cell lines. (B) Motif 
identification on mixed allelic data of DR15-DR51-EBV transformed cell lines. 
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Figure 4. NetMHCIIpan percentile rank score for GibbsCluster solutions in the DR1 and 
DR15/51 data sets. Percentile rank scores were predicted by netMHCIIpan-3.1 for each GibbsCluster 
group with matching alleles present in MS data samples. In the case of the mixed allele dataset 
DR15/51, peptides in the trash cluster were scored by NetMHCIIpan to both DRB1*15:01 and 
DRB5*01:01, selecting the lowest rank score of the two. 
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Figure 5. Generating prediction models from MS ligand data. A) Sequence motifs of the training 
data for three MHC class I alleles, aligned and filtered by GibbsCluster; B) Sequence motifs captured 
by NNAlign-2.0; C) Ligand length preferences in the training MS data compared to length preferences 
learned by the NNAlign model. 
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Figure 6. Comparison of motifs generated by different approaches for three HLA-DR alleles. 
NNAlign-2.0 motifs were obtained by training artificial neural networks on each MS data set, and 
evaluating 100,000 random peptides. The top scoring 1% peptides were used to build logos. Raw MS 
data were aligned, clustered and filtered in an unsupervised manner using GibbsCluster, with a trash 
cluster threshold = 2. The same procedure was applied to tetramer-positive data downloaded from the 
IEDB. Note that due to small data set size, epitope logos are shown in a different y-axis scale. Binding 
motifs for NetMHCIIpan-3.1 were determined by evaluating 100,000 random peptides, and visualizing 
the core motif of the top 1% scoring sequences. 
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Supplementary Figure S1. Sequence motifs of peptides collected by the main cluster and by the 
trash cluster for the 16 alleles in the Abelin data set. 
Supplementary Figure S2. Sequence motifs of peptides collected by the trash cluster on the 7 
alleles in the Bassani-Sternberg data set. 
Supplementary Figure S3. Clustering of the HCC1143 cell lines by GibbsCluster (left) and 
NetMHCpan (right). Sequences were assigned by NetMHCpan to the allele in the haplotype with the 
lowest predicted %rank. If a peptide could be assigned to any MHC allele with rank<=2%, then it was 
discarded to the trash cluster. Note that, in this case, GibbsCluster could not deconvolute HLA-
C*04:01 peptides. 
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